505 (b)(2) Application A 505(b)(2) application is a type of New Drug Application (NDA) in the United States of America that allows a sponsor to obtain U.S. Food and Drug Administration (FDA) approval for a drug by relying, at least in part, on data not developed by the applicant. This can include published literature, studies… Continue reading 505 (b)(2) Application